BOAT: Beta Blocker Uptitration With OptiVol After Cardiac Resynchronization Therapy (CRT)
Status:
Terminated
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
Many heart failure patients are unable to reach target beta blocker doses. This study will
address whether cardiac resynchronization therapy (CRT) will enable uptitration of
beta-blockers to target doses and whether it will favorably affect remodeling by reducing
left ventricular end systolic volume (LVESV), with measurable clinical benefit, beyond CRT
alone (without changes in beta-blocker dose).